T2DM Management in Primary Care Practice
Are your decisions to delay treatment intensification clinical inertia or “appropriate inaction?” Is obesity management a primary treatment goal for your patients with T2DM? Assess how effective you are in achieving short- and long-term therapeutic goals for your patients through our clinical assessment tool and walk away with personalized recommendations and education to address inertia through weight-centric treatment strategies.
Your next steps
3. Not interested in the assessment? Check out the CME activity where expert faculty share best practices for managing patients with dysglycemia and obesity.
Clinical Inertia Assessment Tool
Personalized Education (powered by ACHL Formative Assessment)Do you measure up to addressing better diabetes management through better weight management? Find out as you complete this Clinical Inertia Assessment Tool and receive personalized recommendations and takeaways!
Faculty: Robert Kushner, MD; Donna Ryan, MD
Release Date:
Expiration Date: March 15, 2023
CME/CE is no longer available for this activity
T2DM Management in Primary Care Practice: Addressing the Weight of it All
Clinical Commentary
This expert-led activity offers a “how to” method for introducing strategies that support management of both dysglycemia and obesity. This activity highlights the ramifications of untreated obesity in patients with dysglycemia to underscore the importance of early obesity intervention. It also outlines ways to individualize obesity and dysglycemia management, recognize the benefits of earlier treatment intensification and weight loss, understand the latest data with incretin-based therapies, and optimize strategies to achieve sustained weight loss in patients with T2DM.
Faculty: Robert Kushner, MD; Donna Ryan, MD
Release Date:
Expiration Date: March 15, 2023
CME/CE is no longer available for this activity
